Target intelligence / Profile preview

DiGeorge syndrome critical region gene 2 (DGCR2)

Target
DGCR2
Molecular classification
Adhesion receptor, Integral membrane protein, Other
01

Overview

DGCR2 (DiGeorge syndrome critical region gene 2) encodes an integral membrane protein believed to function as a putative adhesion receptor involved in cell-cell and cell-matrix interactions essential for normal cell differentiation and migration. It plays a key developmental role in neural crest cell migration, cardiac and thymic development, and neural circuit formation. Deletions or changes in DGCR2 within the 22q11.2 chromosomal region cause defects seen in DiGeorge syndrome, including congenital heart disease, thymic deficiency, and neuropsychiatric disorders like schizophrenia and intellectual disability. DGCR2 expression has also been mapped to pancreatic β-cells and is a candidate marker for non-invasive diabetes diagnostics. The molecular properties and broad involvement in development make DGCR2 both a potential disease biomarker and a target for future research.

Other names
Integral membrane protein DGCR2/IDDIDDKIAA0163LANDGS-CSEZ-12DiGeorge syndrome critical region protein 2integral membrane protein deleted in DiGeorge syndrome9930034O06RikmKIAA0163
02

Biological functions

Cell adhesionCell migrationCell differentiationCardiac and thymic developmentNeural circuit formation
03

Disease associations

Congenital heart defectsNeurodevelopmental disordersThymus hypoplasia/aplasia
04

Safety considerations

Gene dosage effectsPotential off-target effects if used as a therapeutic target due to roles in multiple systems
05

Biomarkers

DGCR2 protein on pancreatic β-cellsFluorescence-based diagnostic marker for DiGeorge syndrome

Beyond the preview

Go deeper on DiGeorge syndrome critical region gene 2 (DGCR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DiGeorge syndrome critical region gene 2 (DGCR2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call